CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 4/A Planned sale VP Finance & Operations sold 440 shares at an average $0.37 ($161)
- 4/A Planned sale President and CEO sold 5,225 shares at an average $0.36 ($1,906)
- 4/A Planned sale Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
- 4/A Planned sale VP Finance & Operations sold 224 shares at $0.35 ($78)
- 4/A Planned sale President and CEO sold 2,773 shares at $0.34 ($943)
- 4/A Planned sale Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
- 4 Planned sale Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
- 4 Planned sale VP Finance & Operations sold 440 shares at an average $0.37 ($161)
- 4 Planned sale President and CEO sold 5,225 shares at an average $0.36 ($1,906)
- 4 Planned sale VP Finance & Operations sold 224 shares at $0.35 ($78)
- 4 Open-market sale President and CEO sold 2,773 shares at $0.34 ($943)
- 4 Planned sale Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 18 · 354 filings